Rating History for Innate Pharma S.A. (IPHA) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/29/2025 Swayampakula Ramakanth Upgrade Buy
(Neutral)
5.00
(N/A)
2.09
(1.76)
-15.79% Details